Frederick E. Tan
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
Papers in ⓘ
-
- Protease and Inhibitor Mechanisms 2
- Co-authors
- Ying Chau (2 shared papers)Róbert Langer (2 shared papers)Steven W. Plouffe (1 shared paper)Yunjiang Qiu (1 shared paper)Kimberly C. Lin (1 shared paper)Shenghong Ma (1 shared paper)Zhen Ye (1 shared paper)Bing Ren (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (1 paper)Molecular Cell (1 paper)Bioconjugate Chemistry (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Frederick E. Tan
7 papers receiving 475 citations
Peers
Comparison fields: 5 of 63
- Biomaterials 125
- Cell Biology 152
- Molecular Medicine 22
- Molecular Biology 288
- Cancer Research 61
Countries citing papers authored by Frederick E. Tan
This map shows the geographic impact of Frederick E. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick E. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick E. Tan more than expected).
Fields of papers citing papers by Frederick E. Tan
This network shows the impact of papers produced by Frederick E. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick E. Tan. The network helps show where Frederick E. Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick E. Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 174 | |
| 2 | 2004 | 138 | |
| 3 | 2006 | 71 | |
| 4 | 2020 | 60 | |
| 5 | 2014 | 21 | |
| 6 | 2018 | 12 | |
| 7 | 2021 | 7 |
About Frederick E. Tan
Frederick E. Tan is a scholar working on Immunology and Allergy, Cancer Research, Oncology, Molecular Biology and Cell Biology, having authored 7 papers that have together received 483 indexed citations. Recurring topics across this work include RNA Research and Splicing (4 papers), RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (2 papers), Protease and Inhibitor Mechanisms (2 papers), Peptidase Inhibition and Analysis (2 papers), Ubiquitin and proteasome pathways (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Biomaterials (125 citations), Cell Biology (152 citations), Molecular Medicine (22 citations), Molecular Biology (288 citations) and Cancer Research (61 citations). Frederick E. Tan has collaborated with scholars based in United States. Frequent co-authors include Ying Chau, Róbert Langer, Steven W. Plouffe, Yunjiang Qiu, Kimberly C. Lin, Shenghong Ma, Zhen Ye, Bing Ren, Kun‐Liang Guan and Michael B. Elowitz. Their work appears in journals such as Journal of Pharmaceutical Sciences, Molecular Cell, Bioconjugate Chemistry, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.